Journal of Clinical Densitometry
Volume 14, Issue 3 , Pages 171-180 , July 2011

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX® Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice

  • Didier B. Hans

      Affiliations

    • Department of Bone & Joint, Center of Bone Diseases, Lausanne University Hospital, Lausanne, Switzerland
    • Corresponding Author InformationAddress correspondence to: Didier B. Hans, Ph.D, MBA, Department of Bone & Joint, Center of Bone Diseases, Lausanne University Hospital, Lausanne 1011, Switzerland.
  • ,
  • John A. Kanis

      Affiliations

    • WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, United Kingdom
  • ,
  • Sanford Baim

      Affiliations

    • Division of Endocrinology, University of Miami, Miller School of Medicine, United States of America
  • ,
  • John P. Bilezikian

      Affiliations

    • Columbia University College of Physicians and Surgeons, New York, New York, United States of America
  • ,
  • Neil Binkley

      Affiliations

    • Osteoporosis Clinical Research Program, University of Wisconsin, Madison, WI, United States of America
  • ,
  • Jane A. Cauley

      Affiliations

    • Department of Epidemiology, Graduate School of public Health, University of Pittsburgh, Pittsburgh, United States of America
  • ,
  • Juliet E. Compston

      Affiliations

    • University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
  • ,
  • Cyrus Cooper

      Affiliations

    • MRC Lifecourse Epidemiology Unit, University of Southampton, and NIHR Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford, United Kingdom
  • ,
  • Bess Dawson-Hughes

      Affiliations

    • Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA, United States of America
  • ,
  • Ghada El-Hajj Fuleihan

      Affiliations

    • WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut, Lebanon
  • ,
  • William D. Leslie

      Affiliations

    • University of Manitoba, Winnipeg, Canada
  • ,
  • E. Michael Lewiecki

      Affiliations

    • New Mexico Clinical Research & Osteoporosis Center, University of New Mexico School of Medicine, Albuquerque, NM, United States of America
  • ,
  • Marjorie M. Luckey

      Affiliations

    • St. Barnabas Osteoporosis & Metabolic Bone Disease Center, Livingston, NJ, United States of America
  • ,
  • Eugene V. McCloskey

      Affiliations

    • NIHR Bone Biomedical Research Unit, Centre for Biomedical Research, Northern General Hospital, Herries Road, Sheffield, United Kingdom
  • ,
  • Socrates E. Papapoulos

      Affiliations

    • Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, the Netherlands
  • ,
  • Catalina Poiana

      Affiliations

    • Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • ,
  • René Rizzoli

      Affiliations

    • Division of Bone Diseases, Department of Rehabilitation and Geriatrics, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
  • ,
  • FRAX® Position Development Conference Members

      Affiliations

    • Task Force of the FRAX® Initiative: see “Appendix.”

Received 21 May 2011 ,Accepted 21 May 2011.

References 

  1. Lenchik L, Leib ES, Hamdy RC, et al. Executive summary International Society for Clinical Densitometry position development conference Denver, Colorado July 20–22, 2001. J Clin Densitom. 2002;5(suppl):S1–S3
  2. The Writing Group for the ISCD Position Development Conference. Executive Summary. J Clin Densitom. 2004;7:7–12
  3. The Writing Group for the ISCD Position Development Conference. Diagnosis of osteoporosis in men, premenopausal women and children. J Clin Densitom. 2004;7:17–26
  4. The Writing Group for the ISCD Position Development Conference. Indications and reporting for dual-energy x-ray absorptiometry. J Clin Densitom. 2004;7:37–44
  5. The Writing Group for the ISCD Position Development Conference. Introduction, Methods and Participants. J Clin Densitom. 2004;7:13–15
  6. The Writing Group for the ISCD Position Development Conference. Nomenclature and decimal places in bone densitometry. J Clin Densitom. 2004;7:45–49
  7. Leib ES, Lewiecki EM, Binkley N, et al. Official Positions of the International Society for Clinical Densitometry. J Clin Densitom. 2004;7:1–5
  8. The Writing Group for the ISCD Position Development Conference. Technical standardization for dual-energy x-ray absorptiometry. J Clin Densitom. 2004;7:27–36
  9. Leib ES, Lenchik L, Bilezikian JP, et al. Position statements of the International Society for Clinical Densitometry: Methodology. J Clin Densitom. 2002;5(suppl):S5–S10
  10. Hamdy RC, Petak SM, Lenchik L. Which central dual X-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis?. J Clin Densitom. 2002;5(Suppl):S11–S17
  11. Binkley N, Schmeer P, Wasnich RD, Lenchik L. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians?. J Clin Densitom. 2002;5(suppl):S19–S27
  12. Lenchik L, Kiebzak GM, Blunt BA. What is the role of serial bone mineral density measurements in patient management?. J Clin Densitom. 2002;5:S29–S38
  13. Miller PD, Njeh CF, Jankowski LG, Lenchik L. What are the standards by which bone mass measurement at peripheral skeletal sites should be used in the diagnosis of osteoporosis?. J Clin Densitom. 2002;5(suppl):S39–S45
  14. Binkley N, Bilezikian JP, Kendler DL, et al. Official Positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom. 2006;9:4–14
  15. Shepherd JA, Lu Y, Wilson K, et al. Cross-calibration and minimum precisions standards for dual-energy X-ray absorptiometry: The 2005 ISCD Official Positions. J Clin Densitom. 2006;9:31–36
  16. Hans D, Downs RW, Duboeuf F, et al. Skeletal sites for osteoporosis diagnosis: The 2005 ISCD Official Positions. J Clin Densitom. 2006;9:15–21
  17. Leslie WD, Adler RA, Fuleihan GE, et al. Application of the 1994 WHO Classification to Populations other than postmenopausal Caucasian women: The 2005 ISCD Official Positions. J Clin Densitom. 2006;9:22–30
  18. Vokes T, Bachman D, Baim S, et al. Vertebral Fracture Assessment: The 2005 ISCD Official Positions. J Clin Densitom. 2006;9:37–46
  19. Hans D, Shepherd JA, Schwartz EN, et al. Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom. 2008 Jan-Mar;11(1):188–206
  20. Krieg MA, Barkmann R, Gonnelli S, et al. Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom. 2008 Jan-Mar;11(1):163–187
  21. Engelke K, Adams JE, Armbrecht G, et al. Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom. 2008 Jan-Mar;11(1):123–162
  22. Simonelli C, Adler RA, Blake GM, et al. Dual-Energy X-Ray Absorptiometry Technical issues: the 2007 ISCD Official Positions. J Clin Densitom. 2008 Jan-Mar;11(1):109–122
  23. Schousboe JT, Vokes T, Broy SB, et al. Vertebral Fracture Assessment: the 2007 ISCD Official Positions. J Clin Densitom. 2008 Jan-Mar;11(1):92–108
  24. Baim S, Binkley N, Bilezikian JP, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom. 2008 Jan-Mar;11(1):75–91
  25. Zemel B, Bass S, Binkley T, et al. Peripheral quantitative computed tomography in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom. 2008 Jan-Mar;11(1):59–74
  26. Gordon CM, Bachrach LK, Carpenter TO, et al. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom. 2008 Jan-Mar;11(1):43–58
  27. Bishop N, Braillon P, Burnham J, et al. Dual-energy X-ray aborptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions. J Clin Densitom. 2008 Jan-Mar;11(1):29–42
  28. Rauch F, Plotkin H, DiMeglio L, et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom. 2008 Jan-Mar;11(1):22–28
  29. Baim S, Leonard MB, Bianchi ML, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom. 2008 Jan-Mar;11(1):6–21
  30. Kanis JA World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level. Technical Report. UK: WHO Collaborating Centre, University of Sheffield; 2008;Available at http://www.shef.ac.uk/FRAX/index.htm
  31. Kanis JA, Johnell O, Oden A, et al. FRAX® and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–397
  32. Anonymous 2002 Cochrane Reviews Handbook, vol. 4.1.5. Oxford.
  33. Fitch K, Bernstein SJ, Aguilar MS, et al. The RAND/UCLA Appropriateness Method User's Manual. The RAND Corporation. 2001;
  34. Kanis JA, Hans D, Cooper C, and the Task Force of the FRAX Initiative Interpretation and use of FRAX in clinical practice. 2011 Osteoporosis International. In press.
  35. Lewiecki EM, Compston JE, Miller PD, et al. Official positions for FRAX® bone mineral density and FRAX® simplification. J Clin Densitom. 2011;14:226–236
  36. McCloskey EV, Binkley N FRAX® position development conference members. FRAX® clinical task force of the 2010 joint international society for clinical densitometry & international osteoporosis foundation position development conference. J Clin Densitom. 2011;14:181–183
  37. Broy SB, Tanner SB FRAX® position development conference members. Official positions for FRAX® clinical regarding rheumatoid arthritis. J Clin Densitom. 2011;14:184–189
  38. Dimai HP, Chandran M FRAX® position development conference members. Official positions for FRAX® clinical regarding smoking. J Clin Densitom. 2011;14:190–193
  39. Masud T, Binkley N, Boonen S, Hannan MT FRAX® position development conference members. Official positions for FRAX® clinical regarding falls and frailty: Can falls and frailty be used in FRAX®?. J Clin Densitom. 2011;14:194–204
  40. Blank RD FRAX® position development conference members. Official positions for FRAX® clinical regarding prior fractures. J Clin Densitom. 2011;14:205–211
  41. Leib ES, Saag KG, Adachi JD, et al. FRAX® position development conference members Official positions for FRAX® clinical regarding glucocorticoids: The impact of the use of glucocorticoids on the estimate by FRAX® of the 10 year risk of fracture. J Clin Densitom. 2011;14:212–219
  42. McCloskey EV, Vasikaran S, Cooper C FRAX® position development conference members. Official positions for FRAX® clinical regarding biochemical markers. J Clin Densitom. 2011;14:220–222
  43. Lewiecki EM, Compston JE, Miller PD, et al. FRAX® position development conference members FRAX® bone mineral density task force of the 2010 joint international society for clinical densitometry & international osteoporosis foundation position development conference. J Clin Densitom. 2011;14:223–225
  44. Cauley JA, El-Hajj Fuleihan G, Luckey MM FRAX® position development conference members. FRAX® international task force of the 2010 joint international society for clinical densitometry & international osteoporosis foundation position development conference. J Clin Densitom. 2011;14:237–239
  45. Cauley JA, El-Hajj Fuleihan G, Arabi A, et al. FRAX® position development conference members Official positions for frax® clinical regarding international differences. J Clin Densitom. 2011;14:240–262

PII: S1094-6950(11)00119-3

doi: 10.1016/j.jocd.2011.05.007

Journal of Clinical Densitometry
Volume 14, Issue 3 , Pages 171-180 , July 2011